Filariasis IgG/IgM Rapid Test Device (WB/S/P)

Filariasis is a parasitic disease caused by filarial worms. Lymphatic filariasis is commonly associated with parasites such as Wuchereria bancrofti and Brugia malayi. It can affect the lymphatic system and may lead to swelling, inflammation, and long-term disability in advanced cases.

• The Filariasis IgG/IgM Rapid Test Device helps support fast preliminary screening in clinical and public health settings.
• Rapid screening tools are useful because they are simple, fast, and practical for decentralized healthcare environments.
• The test supports filariasis antibody screening, tropical disease testing programs, field-level screening support, and public health surveillance.
• Differentiation of IgG and IgM antibody response patterns may support better clinical interpretation.

The Filariasis IgG/IgM Rapid Test Device by LARKSOIS Pharma may be used in professional diagnostic and healthcare screening environments.

Applications

• Filariasis antibody screening
• Tropical disease testing programs
• Public health surveillance
• Field-level screening support
• Hospital and clinic workflows
• Differentiation of IgG and IgM response
• Screening in endemic and travel-related cases
• Diagnostic laboratory screening
• International infectious disease testing programs

• The Filariasis IgG/IgM Rapid Test Device works on a lateral flow chromatographic immunoassay principle.
• When the sample is added to the device, it migrates through the test strip.
• If filariasis IgG or IgM antibodies are present, they react with test components and form visible colored lines.
• A control line confirms valid sample flow and proper test performance.

The Filariasis IgG/IgM Rapid Test Device uses rapid lateral flow immunochromatographic technology for qualitative detection and differentiation of filariasis IgG and IgM antibodies from whole blood, serum, or plasma specimens.

Benefits

• Qualitative detection of filariasis IgG antibodies
• Qualitative detection of filariasis IgM antibodies
• Differentiates IgG and IgM antibody patterns
• Suitable for whole blood, serum, or plasma specimens
• Simple visual result interpretation
• No major instrument required
• Supports tropical disease screening workflows
• Suitable for international infectious disease testing programs

The Filariasis IgG/IgM Rapid Test Device is designed for whole blood, serum, or plasma specimens. Correct specimen collection and handling are important for reliable test performance.

Guidance

• Use approved whole blood, serum, or plasma specimens only
• Collect specimens according to the product insert
• Use clean and suitable sample collection materials
• Avoid contaminated or improperly stored samples
• Add whole blood, serum, or plasma to the sample well
• Add buffer as instructed
• Read results only within the recommended time window
• Handle all blood specimens as potentially infectious material

Note

Specimen collection, handling, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The Filariasis IgG/IgM Rapid Test Device by LARKSOIS Pharma is designed to detect and differentiate filariasis IgG and IgM antibodies in whole blood, serum, or plasma specimens. It helps evaluate immune response patterns associated with filarial infection.

• IgM antibodies may suggest a more recent or active immune response to filarial infection.
• IgG antibodies may suggest later-stage immune response, past exposure, or previous infection.
• Healthcare professionals should interpret results with symptoms, endemic exposure, travel history, and confirmatory testing.
• The test may support clinical screening workflows in endemic and tropical disease regions.

The Filariasis IgG/IgM Rapid Test Device is a screening aid and should not be the only basis for diagnosis. Results should be interpreted with medical history, symptoms, travel or endemic exposure, and other diagnostic methods.

Instructions

• The test does not always confirm active infection
• The test does not measure parasite burden
• The test does not identify exact filarial species
• Incorrect specimen handling may affect results
• Antibodies may remain detectable after previous exposure
• False positive or false negative results may occur
• Results should be interpreted with clinical findings
• Additional laboratory testing may be required

Instructions

• Rapid qualitative detection of filariasis IgG antibodies
• Rapid qualitative detection of filariasis IgM antibodies
• Differentiates IgG and IgM immune response patterns
• Suitable for whole blood, serum, or plasma specimens
• Simple visual result interpretation
• No major instrument required
• Supports field-level healthcare and public health screening
• Useful for hospitals, clinics, and laboratories

Note

The Filariasis IgG/IgM Rapid Test Device by LARKSOIS Pharma is developed for professional users who need practical and accessible filariasis screening support.

Steps

• Bring the test device, sample, and buffer to room temperature
• Remove the cassette from the sealed pouch
• Place it on a clean and flat surface
• Add whole blood, serum, or plasma to the sample well
• Add buffer as instructed
• Wait for the recommended reaction time
• Read IgG, IgM, and control lines within the valid time window
• Do not read results after the recommended time
• Dispose of used materials according to laboratory safety rules

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

IgM positive / IgG negative may suggest a recent or active immune response to filarial infection. IgG positive / IgM negative may suggest past exposure, later-stage immune response, or previous infection. IgG positive / IgM positive may suggest ongoing or recent immune response.

Negative

IgG negative / IgM negative means no detectable filariasis IgG or IgM antibodies were found. If symptoms or exposure risk remain, further testing may be needed.

Invalid

If the control line does not appear, the test is invalid and should be repeated with a new device according to the product insert.

Instructions

• Store the Filariasis IgG/IgM Rapid Test Device according to the label and product insert
• Store in a dry place
• Keep sealed until use
• Do not freeze
• Protect from moisture
• Avoid direct sunlight
• Do not use expired kits
• Use immediately after opening the pouch

Instructions

• For professional in-vitro diagnostic use only
• Handle all blood samples as potentially infectious
• Wear gloves during sample handling
• Do not reuse the test cassette
• Avoid specimen cross-contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Confirm results with clinical evaluation when required

LARKSOIS Pharma provides international-quality diagnostic products for hospitals, clinics, laboratories, importers, distributors, NGOs, and public health organizations. The Filariasis IgG/IgM Rapid Test Device is designed for rapid, practical, and accessible infectious disease screening using whole blood, serum, or plasma.

Advantages

• International diagnostic product focus
• Reliable rapid testing solutions
• Suitable for hospitals, clinics, and laboratories
• Distributor-friendly product format
• Supports tropical disease screening workflows
• Practical WB/S/P testing format
• Quality-focused standards under LARKSOIS Pharma